Cargando…
Long Noncoding RNAs: New Regulators of Resistance to Systemic Therapies for Gastric Cancer
Gastric cancer (GC) is the second leading cause of cancer mortality and the fourth most commonly diagnosed malignant disease, with approximately 951,000 new cases diagnosed and approximately 723,000 cases of mortality each year. The highest mortality rate of GC is in East Asia, and the lowest is in...
Autores principales: | Sun, Weihong, Jiang, Changqing, Ji, Ying, Xiao, Chao, Song, Haiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808844/ https://www.ncbi.nlm.nih.gov/pubmed/33506041 http://dx.doi.org/10.1155/2021/8853269 |
Ejemplares similares
-
Molecular mechanisms of long noncoding RNAs on gastric cancer
por: Li, Tianwen, et al.
Publicado: (2016) -
Long noncoding RNA associated-competing endogenous RNAs in gastric cancer
por: Xia, Tian, et al.
Publicado: (2014) -
Epithelial-mesenchymal transition-related long noncoding RNAs in gastric carcinoma
por: Feng, Ying-Nan, et al.
Publicado: (2022) -
Long noncoding RNAs in gastric cancer: functions and clinical applications
por: Wang, Jiajun, et al.
Publicado: (2016) -
Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis
por: Gao, Song, et al.
Publicado: (2018)